Disc Medicine, Inc.
IRON
$58.97
-$0.79-1.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 24.92% | 19.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.62% | 5.16% | |||
| Operating Income | -15.62% | -5.16% | |||
| Income Before Tax | -16.00% | -10.56% | |||
| Income Tax Expenses | -32.39% | 54.39% | |||
| Earnings from Continuing Operations | -15.71% | -10.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -15.71% | -10.74% | |||
| EBIT | -15.62% | -5.16% | |||
| EBITDA | -15.59% | -5.16% | |||
| EPS Basic | -4.14% | -10.53% | |||
| Normalized Basic EPS | -4.41% | -10.33% | |||
| EPS Diluted | -4.14% | -10.53% | |||
| Normalized Diluted EPS | -4.41% | -10.33% | |||
| Average Basic Shares Outstanding | 11.10% | 0.20% | |||
| Average Diluted Shares Outstanding | 11.10% | 0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||